Location History:
- Kent Vale, SG (2017)
- Singapore, SG (2023)
Company Filing History:
2 out of 260 
1 out of 811 
Years Active: 2017-2023
Title: Elaine Coustan-Smith: Innovator in Leukemia Research
Introduction
Elaine Coustan-Smith is a prominent inventor based in Singapore, known for her significant contributions to the field of leukemia research. With a focus on minimal residual disease, her work has the potential to greatly impact the diagnosis and treatment of acute myeloid leukemia and acute lymphoblastic leukemia. She holds 2 patents that reflect her innovative approach to medical science.
Latest Patents
One of her latest patents is titled "Approach for universal monitoring of minimal residual disease in acute myeloid leukemia." This invention describes methods for detecting the presence of proteins in a subject, which can be indicative of acute myeloid leukemia (AML). The proteins identified can be particularly useful for monitoring minimal residual disease (MRD) in AML. Another significant patent is "Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia." This invention provides methods and kits for diagnosing and ascertaining the clinical course of minimal residual disease associated with acute lymphoblastic leukemia (ALL). It specifically offers methods and kits useful in the diagnosis and determination of clinical parameters associated with diseases related to ALL based on unique patterns of surface marker expression.
Career Highlights
Elaine has worked with esteemed organizations such as St. Jude Children's Research Hospital and the National University of Singapore. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of her notable collaborators is Dario Campana, with whom she has worked closely on various research projects.
Conclusion
Elaine Coustan-Smith's innovative work in leukemia research exemplifies her dedication to improving patient outcomes through scientific advancements. Her patents and collaborations highlight her role as a key figure in the medical research community.